Published on | 4 months ago
Programmes Digital, Industry & Space HPC AI, data & cloudThe EuroHPC Joint Undertaking (EuroHPC JU) has launched two calls for expressions of interest to select hosting entities that will host and operate AI-optimised supercomputers, AI experimental platforms and AI factories across Europe, to be funded under the Digital Europe programme.
EuroHPC will deploy AI-dedicated supercomputing and service infrastructures to support the further development of a highly competitive and innovative AI Ecosystem in the European Union.
The AI Factories initiative seeks to establish a number of comprehensive one-stop shops for AI users, including start-ups, small and medium-sized enterprises (SMEs), and scientific researchers. They will provide streamlined access to a wide range of AI services, including essential tools, skills development, and user support. The aim of AI factories is to provide the European scientific community at large with enhanced access to AI optimised computing capabilities for the large-scale training and development of general-purpose AI models, and for the development, validation and running of emerging AI applications.
The two calls for expressions of interest are each tailored to different types of hosting entities:
Both calls have multiple cut-off dates and will remain open until the final deadline on 31 December 2025. The first cut-off deadline for applications is 4 November 2024.
More information on the two calls can be found in the EuroHPC press release.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Digital, Industry & Space Cybersecurity Defence EDF
We hereby want you to give an overview of the known activities related to the EDF 2025 calls: Publication of the European Defence Fund (EDF) Work Programme 2025 infosessions: Belgian and Flanders EDF infoday on February 20th in Brussels The EDF Info Days 2025 will take place on 2-3 April in hybrid format in&n... read more
Digital, Industry & Space AI, data & cloud Deployment: Best use of technologies
The European Commission has published guidelines on prohibited artificial intelligence (AI) practices, as defined by the EU AI Act. The guidelines provide an overview of AI practices that are considered unacceptable due to their potential risks to European values and fundamental rights. The AI Act, which aims to promote innovation while... read more
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.